These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28670192)

  • 1. The Occurrence of Subclinical Hypercortisolism and Osteoporosis in Patients with Incidentally Discovered Unilateral and Bilateral Adrenal Tumors.
    Ognjanović S; Macut D; Petakov M; Elezović Kovačević V; Isailović T; Bozić Antić I; Ilić D; Popović B; Bogavac T; Pekmezović T; Damjanović S
    J Med Biochem; 2016 Oct; 35(4):401-409. PubMed ID: 28670192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral and unilateral adrenal incidentalomas: biochemical and clinical characteristics.
    Morelli V; Palmieri S; Salcuni AS; Eller-Vainicher C; Cairoli E; Zhukouskaya V; Scillitani A; Beck-Peccoz P; Chiodini I
    Eur J Endocrinol; 2013 Feb; 168(2):235-41. PubMed ID: 23169694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does subclinical hypercortisolism adversely affect the bone mineral density of patients with adrenal incidentalomas?
    Hadjidakis D; Tsagarakis S; Roboti C; Sfakianakis M; Iconomidou V; Raptis SA; Thalassinos N
    Clin Endocrinol (Oxf); 2003 Jan; 58(1):72-7. PubMed ID: 12519415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas.
    Tsagarakis S; Roboti C; Kokkoris P; Vasiliou V; Alevizaki C; Thalassinos N
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):165-71. PubMed ID: 9828902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fracture risk and bone health in adrenal adenomas with mild autonomous cortisol secretion/subclinical hypercortisolism: a systematic review, meta-analysis and meta-regression.
    Pal R; Banerjee M; Prasad TN; Walia R; Bhadada T; Singh J; Bhadada SK
    J Bone Miner Res; 2024 Aug; 39(7):885-897. PubMed ID: 38703381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone quality, as measured by trabecular bone score in patients with adrenal incidentalomas with and without subclinical hypercortisolism.
    Eller-Vainicher C; Morelli V; Ulivieri FM; Palmieri S; Zhukouskaya VV; Cairoli E; Pino R; Naccarato A; Scillitani A; Beck-Peccoz P; Chiodini I
    J Bone Miner Res; 2012 Oct; 27(10):2223-30. PubMed ID: 22549969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral adrenal incidentalomas differ from unilateral adrenal incidentalomas in subclinical cortisol hypersecretion but not in potential clinical implications.
    Vassilatou E; Vryonidou A; Ioannidis D; Paschou SA; Panagou M; Tzavara I
    Eur J Endocrinol; 2014 Jul; 171(1):37-45. PubMed ID: 24743396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
    Tsagarakis S; Kokkoris P; Roboti C; Malagari C; Kaskarelis J; Vlassopoulou V; Alevizaki C; Thalassinos N
    Clin Endocrinol (Oxf); 1998 May; 48(5):627-33. PubMed ID: 9666875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of cortisol and adrenal androgen on bone mass in Asians with and without subclinical hypercortisolism.
    Ahn SH; Kim JH; Cho YY; Suh S; Kim BJ; Hong S; Lee SH; Koh JM; Song KH
    Osteoporos Int; 2019 May; 30(5):1059-1069. PubMed ID: 30719548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications.
    Tsagarakis S; Vassiliadi D; Thalassinos N
    J Endocrinol Invest; 2006 May; 29(5):471-82. PubMed ID: 16794373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eugonadal male patients with adrenal incidentalomas and subclinical hypercortisolism have increased rate of vertebral fractures.
    Chiodini I; Viti R; Coletti F; Guglielmi G; Battista C; Ermetici F; Morelli V; Salcuni A; Carnevale V; Urbano F; Muscarella S; Ambrosi B; Arosio M; Beck-Peccoz P; Scillitani A
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):208-13. PubMed ID: 18547342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical hypercortisolism and CT appearance in adrenal incidentalomas: a multicenter study from Southern Sweden.
    Olsen H; Nordenström E; Bergenfelz A; Nyman U; Valdemarsson S; Palmqvist E
    Endocrine; 2012 Aug; 42(1):164-73. PubMed ID: 22350586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
    Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and clinical benefits of unilateral adrenalectomy in patients with subclinical hypercortisolism and bilateral adrenal incidentalomas.
    Perogamvros I; Vassiliadi DA; Karapanou O; Botoula E; Tzanela M; Tsagarakis S
    Eur J Endocrinol; 2015 Dec; 173(6):719-25. PubMed ID: 26330465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas.
    Reimondo G; Allasino B; Bovio S; Saba L; Ardito A; Angeli A; Terzolo M
    J Endocrinol Invest; 2011 Jan; 34(1):e1-5. PubMed ID: 20634637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activity of 11β-hydroxysteroid dehydrogenase type 2 enzyme and cortisol secretion in patients with adrenal incidentalomas.
    Morelli V; Polledri E; Mercadante R; Zhukouskaya V; Palmieri S; Beck-Peccoz P; Spada A; Fustinoni S; Chiodini I
    Endocrine; 2016 Sep; 53(3):809-15. PubMed ID: 26438395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry in the diagnosis of subclinical hypercortisolism.
    Palmieri S; Morelli V; Polledri E; Fustinoni S; Mercadante R; Olgiati L; Eller Vainicher C; Cairoli E; Zhukouskaya VV; Beck-Peccoz P; Chiodini I
    Eur J Endocrinol; 2013 Mar; 168(3):289-96. PubMed ID: 23211572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density, prevalence of vertebral fractures, and bone quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism: an Italian multicenter study.
    Chiodini I; Morelli V; Masserini B; Salcuni AS; Eller-Vainicher C; Viti R; Coletti F; Guglielmi G; Battista C; Carnevale V; Iorio L; Beck-Peccoz P; Arosio M; Ambrosi B; Scillitani A
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3207-14. PubMed ID: 19549741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical Cushing's syndrome in adrenal incidentaloma.
    Terzolo M; Osella G; Alì A; Borretta G; Cesario F; Paccotti P; Angeli A
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):89-97. PubMed ID: 9509073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma.
    Masserini B; Morelli V; Bergamaschi S; Ermetici F; Eller-Vainicher C; Barbieri AM; Maffini MA; Scillitani A; Ambrosi B; Beck-Peccoz P; Chiodini I
    Eur J Endocrinol; 2009 Jan; 160(1):87-92. PubMed ID: 18835977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.